|
HNRNPA2B1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.96238597488718E-13 |
| Normal-vs-Stage2 |
2.10110000509189E-08 |
| Normal-vs-Stage3 |
7.33857419277228E-14 |
| Normal-vs-Stage4 |
1.74105174721717E-12 |
| Stage1-vs-Stage2 |
7.142800E-01 |
| Stage1-vs-Stage3 |
1.901740E-02 |
| Stage1-vs-Stage4 |
2.898400E-02 |
| Stage2-vs-Stage3 |
2.401200E-01 |
| Stage2-vs-Stage4 |
1.667150E-01 |
| Stage3-vs-Stage4 |
7.747000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44249065417534E-15 |
| Normal-vs-AfricanAmerican |
3.85840000000082E-05 |
| Normal-vs-Asian |
5.90909998710032E-09 |
| Caucasian-vs-AfricanAmerican |
2.963200E-01 |
| Caucasian-vs-Asian |
4.167400E-01 |
| AfricanAmerican-vs-Asian |
6.755400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.90558721316847E-14 |
| Normal-vs-Female |
1.63569158218024E-12 |
| Male-vs-Female |
5.800000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.96207502969992E-12 |
| Normal-vs-Age(41-60Yrs) |
1.73594472130389E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63147273468667E-12 |
| Normal-vs-Age(81-100Yrs) |
4.19889999999645E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.743200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.854300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.574200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.382000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.567400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.113400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.393100E-04 |
| Classical-VS-Follicular |
2.286200E-01 |
| Classical-VS-Other |
4.725200E-01 |
| Classical-VS-Normal |
1.72395431263794E-12 |
| Tall-VS-Follicular |
1.711910E-02 |
| Tall-VS-Other |
2.411000E-01 |
| Tall-VS-Normal |
2.00373051484348E-12 |
| Follicular-VS-Other |
8.724200E-01 |
| Follicular-VS-Normal |
3.30069971354874E-10 |
| Other-VS-Normal |
7.408600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29785071578681E-13 |
| Normal-vs-N1 |
7.7242989782178E-11 |
| N0-vs-N1 |
8.982800E-01 |
|
|
